Part D

The Top Six Ways Trump’s Policies Will Impact Pharmacies
The Top Six Ways Trump’s Policies Will Impact PharmaciesHow the new Trump administration will affect everything from the ACA to the FDA.
Value-based care takes over J.P. Morgan Healthcare Conference 2017Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.
Four ways Medicare Part D has affected costs for diabetic patientsUnderstand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients.
BLOG: Close call for Rx marketers on Part DWhy would HHS disrupt Part D when it's been a success for plans and for seniors?
Pharmacy groups applaud Part D backpedalAMCP and NCPA are generally relieved that feds won't interfere with drug prices
Antidepressants may be kicked off protected drug listSix protected drug classes could be whittled down to three by 2016
Fact File: New Part D rule changesGet caught up on CMS proposals for Part D networks, mail order and price negotiations
Medicare hits plans with another 3% cutSeen as a 'war on seniors'
Part D's history might be a benchmark for ACA rolloutWill ACA exchanges earn 90% satisfaction ratings someday?
Exchange formularies need flexibility beyond PPACAPharmacy leaders say benchmark plans too limited and PPACA too prescriptive